- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
VODOBAT REPORT AT TAM DUC HEART HOSPITAL
On August 2, 2023, Medbolide CPDP Company attended the Science and Technology Activity at Tam Duc Heart Hospital - one of the leading Cardiology hospitals in Ho Chi Minh City. Representative of Medbolide CPDP Company gave a presentation with the topic "VODOCAT (Torsemide 5 mg) - Breakthrough in diuretics".
The presentation clarified the superior advantages of Torsemide compared to Furosemide, based on scientific evidence from clinical studies. Torsemide is recommended for treatment by reputable cardiovascular associations, the Vietnam Heart Association and the Vietnam Ministry of Health. The product's benefits have received recognition and appreciation from the doctors attending the event.
The event was chaired by Associate Professor Dr. Ton That Minh - Director of Tam Duc Heart Hospital and took place successfully with the participation of all the Hospital's Doctors and Pharmacists. Medbolide Joint Stock Company is very pleased to accompany Tam Duc Heart Hospital in the process of taking care of patients' health.
Readers comments